FDA Archives - BioPharmaJournal

The FDA Has Increased The Review Time For Amylyx Pharmaceuticals Inc’s...

Gavins Felicity - June 15, 2022 0

BioCardia Inc (NASDAQ: BCDA) Receives an IND for BCDA-04

Matt Wade - April 18, 2022 0

The FDA Issues Approval to the Latest ADMA Biologics Inc (NASDAQ:...

Kate Hudson - March 14, 2022 0

Akebia Therapeutics Inc. (NASDAQ: AKBA) Amends and Restates Terms of Agreement...

Kate Hudson - March 4, 2022 0

BioLineRx Ltd. (NASDAQ: BLRX) Completes pre-NDA meeting on Motixafortide as a...

Gavins Felicity - February 8, 2022 0

PolarityTE Inc. (NASDAQ: PTE) Receives FDA approval for IND for SkinTE...

Gavins Felicity - January 25, 2022 0

Health Equity Experts Question COVID-19 Booster Shots When Some In Developing...

Gavins Felicity - November 4, 2021 0

Regulus Therapeutics Inc. (NASDAQ: RGLS) strategically Prioritizing RGLS8429 for Autosomal Dominate...

Kate Hudson - October 18, 2021 0

Amicus Therapeutics, Inc. (NASDAQ: FOLD) Announces that it is Preparing to...

Gavins Felicity - October 12, 2021 0

Impel NeuroPharma Inc. (NASDAQ: IMPL) Launches Trudhesa Nasal Spray For Prescription...

Kate Hudson - October 8, 2021 0

12 3...7 Page 1 of 7

CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment...

Gavins Felicity - July 5, 2022 0

CymaBay Therapeutics Inc (NASDAQ: CBAY) has announced the presentation of promising seladelpar findings in primary biliary cholangitis (PBC) patients at The International Liver Congress...

Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA

July 4, 2022

Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan...

July 1, 2022

Cannabis Stocks Deeply Oversold with Big Growth Ahead (TLRY, SGMD, OGI,...

June 30, 2022

Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes...

June 30, 2022

Tag: FDA

Recent Post